Home LiteratureArticle Details
PMID: 10595919 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.

The American journal of pathology ·Vol. 155 ·No. 6 ·1999-12-00 ·Pages 1885-91

Kourea HP, Cordon-Cardo C, Dudas M, Leung D, Woodruff JM

Abstract

There is little information regarding the status of cell cycle regulators in malignant peripheral nerve sheath tumors (MPNSTs) and neurofibromas (NFs). In this study, we investigated patterns of expression of p53 and pRB, cyclin-dependent kinase inhibitors (CKIs) p21 and p27, as well as cyclins D1 and E, in a cohort of 35 well-characterized MPNSTs and 16 NFs. These phenotypes were correlated with proliferative index, as assessed by Ki-67, as well as clinicopathological parameters of poor outcome. p53 nuclear overexpression was found in 10 of 35 (29%) MPNSTs, and it was lacking in NFs (P = 0.02). There were no differences in the patterns of expression of pRB, cyclin D1, and p21 between MPNSTs and NFs. However, p27 nuclear expression was present in most NFs, but it was absent in the majority of MPNSTs, which displayed cytoplasmic staining (P < 0.001). Nuclear cyclin E expression was more pronounced in MPNSTs than in NFs. We observed inverse patterns of expression for nuclear p27 and nuclear cyclin E expression. The staining profiles of cytoplasmic p27 and nuclear cyclin E expression were found to be statistically associated (P = 0.01). High Ki-67 expression was found in 20 of 34 (59%) MPNSTs but was absent in NFs (P < 0.001). Furthermore, detection of cytoplasmic p27 expression was found to be a prognostic factor for poor survival in MPNSTs (P = 0.03, relative risk = 2.4).

MeSH Terms
Cell Cycle/physiology Cell Cycle Proteins Cell Division Cell Transformation, Neoplastic/genetics Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases/antagonists & inhibitors Enzyme Inhibitors Gene Expression Genes, Tumor Suppressor Humans Immunohistochemistry Ki-67 Antigen/metabolism Microtubule-Associated Proteins/genetics,metabolism Nerve Sheath Neoplasms/genetics,metabolism,pathology Neurofibroma/genetics,metabolism,pathology Phenotype Prognosis Proportional Hazards Models Tumor Suppressor Proteins
Chemicals
Cell Cycle Proteins Enzyme Inhibitors Ki-67 Antigen Microtubule-Associated Proteins Tumor Suppressor Proteins Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kourea H P
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. kouma@otenet.gr
Cordon-Cardo C
Dudas M
Leung D
Woodruff J M
References (38)
38 references, click to expand
  1. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4.
    Mol Cell Biol. 1995 May;15(5):2682-8 PMID: 7739548
  2. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.
    Mol Cell Biol. 1995 May;15(5):2612-24 PMID: 7739542
  3. Role of the cyclin-dependent kinase inhibitors in the development of cancer.
    Blood. 1995 Aug 1;86(3):841-54 PMID: 7620180
  4. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Science. 1995 Aug 4;269(5224):682-5 PMID: 7624798
  5. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.
    Am J Pathol. 1995 Sep;147(3):545-60 PMID: 7677168
  6. Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas.
    Br J Cancer. 1995 Oct;72(4):986-91 PMID: 7547254
  7. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours.
    Virchows Arch. 1995;427(1):19-26 PMID: 7551341
  8. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.
    Oncogene. 1996 Mar 21;12(6):1173-80 PMID: 8649818
  9. p53 expression in neurofibroma and malignant peripheral nerve sheath tumor. An immunohistochemical study of sporadic and NF1-associated tumors.
    Am J Clin Pathol. 1996 Sep;106(3):282-8 PMID: 8816583
  10. Cyclin E-CDK2 is a regulator of p27Kip1.
    Genes Dev. 1997 Jun 1;11(11):1464-78 PMID: 9192873
  11. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53.
    Cancer Res. 1998 Mar 15;58(6):1090-4 PMID: 9515785
  12. Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors.
    Cancer. 1998 Jun 1;82(11):2191-203 PMID: 9610699
  13. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
    Anticancer Res. 1998 Jul-Aug;18(4A):2403-8 PMID: 9703886
  14. New insights into the tumor suppression function of P27(kip1)
    Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15158-60 PMID: 9860936
  15. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.
    Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15653-8 PMID: 9861025
  16. Peripheral nerve sheath tumors: an electron microscopic study of 43 cases.
    Cancer. 1982 Jan 15;49(2):273-87 PMID: 7053827
  17. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases.
    Cancer. 1986 May 15;57(10):2006-21 PMID: 3082508
  18. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity.
    Nature. 1987 Oct 15-21;329(6140):642-5 PMID: 3657987
  19. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
    Proc Natl Acad Sci U S A. 1990 Jul;87(14):5435-9 PMID: 2142531
  20. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases.
    Cancer. 1990 Sep 15;66(6):1253-65 PMID: 2119249
  21. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.
    Science. 1992 Oct 16;258(5081):424-9 PMID: 1411535
  22. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
    Cell. 1992 Oct 16;71(2):323-34 PMID: 1423597
  23. Physical interaction of the retinoblastoma protein with human D cyclins.
    Cell. 1993 May 7;73(3):499-511 PMID: 8490963
  24. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  25. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  26. p21 is a universal inhibitor of cyclin kinases.
    Nature. 1993 Dec 16;366(6456):701-4 PMID: 8259214
  27. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Nature. 1993 Dec 16;366(6456):704-7 PMID: 8259215
  28. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
    Mol Cell Biol. 1994 Mar;14(3):2077-86 PMID: 8114739
  29. Induction of WAF1/CIP1 by a p53-independent pathway.
    Cancer Res. 1994 Jul 1;54(13):3391-5 PMID: 8012956
  30. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
    Cell. 1994 Jul 15;78(1):59-66 PMID: 8033212
  31. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
    Cell. 1994 Jul 15;78(1):67-74 PMID: 8033213
  32. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.
    Nature. 1994 Sep 15;371(6494):257-61 PMID: 8078588
  33. TP53 mutations are frequent in malignant NF1 tumors.
    Genes Chromosomes Cancer. 1994 Aug;10(4):250-5 PMID: 7522538
  34. G1 phase progression: cycling on cue.
    Cell. 1994 Nov 18;79(4):551-5 PMID: 7954821
  35. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Genes Dev. 1994 Dec 15;8(24):2939-52 PMID: 8001816
  36. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.
    Cancer Res. 1995 Mar 15;55(6):1211-4 PMID: 7882310
  37. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
    Genes Dev. 1995 Mar 15;9(6):639-49 PMID: 7729683
  38. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
    Cancer Res. 1995 Jun 1;55(11):2266-9 PMID: 7757974
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1999-12-00
Pages
1885-91
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1866917
Subset
IM
Grants
NCI NIH HHS · P01 CA047179 · United States
NCI NIH HHS · CCA47179 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com